NIH established Centers for Research in Emerging Infectious Diseases
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
Assembly Biosciences and Arbutus announced collaboration to evaluate combination of core inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in patients with Chronic Hepatitis B Virus Infection
On Aug. 27, 2020, Assembly Biosciences and Arbutus Biopharma announced that the companies have entered into a clinical…
University of Oxford study described which cancer patients are more vulnerable to COVID-19
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19
On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
NIH-supported research demonstrates how genetic variations cause eczema
On Aug. 14, 2020, research supported by the National Institutes of Health delineated how two relatively common variations…
ADHD risk may be linked to inflammation during pregnancy
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
Biotechnology | Disease | FDA | Therapeutics
FDA approved oral treatment for spinal muscular atrophy
On Aug. 7, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Evrysdi (risdiplam) to treat patients…
Biotechnology | CDC | Diagnostics | Disease | Neurology | Therapeutics
CDC announced that 2020 outbreak of life-threatening acute flaccid myelitis expected
On Aug. 4, 2020, The Centers for Disease Control and Prevention (CDC) anticipates that 2020 will be another…
NIH-funded project created an encyclopedia detailing the inner workings of the human and mouse genomes
On Jul. 29, 2020, the Encyclopedia of DNA Elements (ENCODE) Project is a worldwide effort to understand how…
Secrets of naked mole-rat cancer resistance unearthed
On Jul. 21, 2020, researchers at the University of Cambridge have shown for the first time that genes…
Oxford Immunotec announced agreement with Stop TB Partnership to access to the T-SPOTTB test for 100+ countries
On Jul. 20, 2020, Oxford Immunotec announced that it had entered into a long-term agreement to supply its…
Biotechnology | COVID-19 | Disease | Therapeutics | WHO
Access to HIV medicines severely impacted by COVID-19 as AIDS response stalled
On Jul. 8, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
European Investment Bank and EC provided CureVac with $75 million financing for vaccine development and expansion of manufacturing
On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…
Biotechnology | Disease | FDA
Luminex submitted Emergency Use Authorization request to FDA for COVID-19 antibody test
On Jun. 29, 2020, Luminex announced that the company had submitted an Emergency Use Authorization request to the…
The 10th Ebola outbreak in the Democratic Republic of the Congo was declared over
On Jun. 25, 2020, the World Health Organization (WHO) announced the end of the 10th outbreak of Ebola…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
Seattle researchers teamed up to build hi-res brain map of Alzheimer’s disease
On Jun. 25, 2020, the Allen Institute announced a new a new $40.5 million collaborative research center in…
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHD
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital…
NIH study linked cigarette smoking to higher stroke risk in African Americans
On Jun. 10, 2020, African Americans who smoke are nearly 2.5 times more likely to have a stroke…
Disease | Therapeutics | WHO
No link between two ongoing Ebola outbreaks in the Democratic Republic of the Congo
On Jun. 9, 2020, new genetic sequence analysis by the Democratic Republic of the Congo’s (DRC) National Institute…
Largest catalog of human genetic diversity released
On Jun. 9, 2020, an international gnomAD team of over 100 scientists released its first set of discoveries…
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH researchers uncovered genes linked to common recurrent fever in children
On Jun. 8, 2020, researchers at the National Human Genome Research Institute announced they had discovered clues to…
International gnomAD Consortium released first major studies of human genetic variation
On May 27, 2020, an analyses of the largest publicly available catalog of human genomic data revealed new…
Biotechnology | COVID-19 | Disease | Infectious Disease | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
Autism risk estimated at 3 to 5% for children whose parents have a sibling with autism
On May 18, 2020, the NIH reported that roughly 3 to 5% of children with an aunt or…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
FDA approved first targeted therapy to treat aggressive form of lung cancer
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
Clinical trial began to see if convalescent plasma can treat COVID-19
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
Windtree announced first patient enrolled in AEROSURF bridging study for treatment of Respiratory Distress Syndrome
On Apr. 29, 2020, Windtree Therapeutics announced it has enrolled the first patient into its AEROSURF phase 2b…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new therapy for triple negative breast cancer
On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy),…
Oxford Immunotec announced successful re-registration of the T-SPOT.TB test in China
On Apr. 21, 2020, University of Oxford announced that it had successfully obtained re-registration of the T-SPOT.TB test…
VA researchers announced study of COVID-19 in aging Veterans with dementia
On Apr. 21, 2020, researchers at the U.S. Department of Veterans Affairs’ (VA) Providence VA Medical Center began…